References

1. 1.
   SUN J X，WEI Y，WANG J，et al.Treatment of colorectal cancer by traditional Chinese medicine：Prevention and treatment mechanisms［J］.Front Pharmacol，2024，15：1377592.
2. 2.
   BRAY F，LAVERSANNE M，SUNG H，et al.Global cancer statistics 2022：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2024，74（3）：229-263.
3. 3.
   Society of Breast Cancer China Anti-Cancer Association， Breast Oncology Group of the Oncology Branch of the Chinese Medical Association.Guidelines for breast cancer diagnosis and treatment by China anti-cancer association（2024 edition）［J］.China Oncol，2023，33（12）：1092-1187.
4. 4.
   YE F，DEWANJEE S，LI Y H，et al.Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer［J］.Mol Cancer，2023，22（1）：105.
5. 5.
   LIU Y，HU Y T，XUE J Q，et al.Advances in immunotherapy for triple-negative breast cancer［J］.Mol Cancer，2023，22（1）：145.
6. 6.
   HONG R X，XU B H.Breast cancer：An up-to-date review and future perspectives［J］.Cancer Commun （Lond），2022，42（10）：913-936.
7. 7.
   SUNG H，FERLAY J，SIEGEL R L，et al.Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2021，71（3）：209-249.
8. 8.
   KOUAL M，TOMKIEWICZ C，CANO-SANCHO G，et al.Environmental chemicals，breast cancer progression and drug resistance［J］.Environ Health，2020，19（1）：117
9. 9.
   HALL L H，KING N V，GRAHAM C D，et al.Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors：An umbrella review of empirical evidence and clinical guidelines［J］.J Cancer Surviv，2022，16（6）：1296-1338.
10. 10.
    ZHANG M J，ZHANG C H，ZHANG T S.Research progress in the treatment of postoperative complications of breast cancer by traditional Chinese medicine［J］.China Mod Dr，2024， 62（10）：99-101.
11. 11.
    XU S Y，LIAO S Y，ZHANG T X，et al.Effects of total flavone extract from Ampelopsis megalophylla mediated by autophagy inhibitor 3-MA on proliferation and apoptosis of human breast cancer cells［J］.Chin Pharmacol Bull，2024，40（6）：1115-1123.
12. 12.
    LUO F，WAN D G，LIU J，et al.Efficacy of the traditional Chinese medicine，Buyang Huanwu decoction，at preventing taxane-induced peripheral neuropathy in breast cancer patients：A prospective，randomized，controlled study［J］.Medicine （Baltimore），2024，103（9）：e37338.
13. 13.
    YU Q H，XU C C，SONG J Q，et al.Mechanisms of traditional Chinese medicine/natural medicine in HR-positive breast cancer：A comprehensive literature review［J］.J Ethnopharmacol，2024，319（Pt 3）：117322.
14. 14.
    LI H K，LI J W，ZHANG Y F，et al.The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway［J］.Front Pharmacol，2024，15：1401979.
15. 15.
    CHEN C，WANG C H，YAO D J.Discussion on thoughts of treatment of breast cancer based on theory of six Fu-organs functioning well when unobstructed［J］.J Oncol Chin Med，2019，1（5）：6-8.
16. 16.
    SANG Y T，LI J.Li Jie's clinical experience in treating breast cancer by soothing liver and strengthening spleen［J］.J Basic Chin Med，2020，26（6）：844-846.
17. 17.
    SHI W W，ZHANG L，WU Y M，et al.Study on the dialectical relationship between TCM theory and tumor immunotherapy［J］.Liaoning J Tradit Chin Med，2025，52（4）：39-42.
18. 18.
    ZHUO Z L，SONG Q Y，LU W P，et al.Exploring the clinical approach of treating breast cancer in traditional Chinese medicine through syndrome differentiation based on the nature and intensity of the cancer toxin［J］.China J Inf Tradit Chin Med，2024，31（8）：176-181.
19. 19.
    LIU D G，LI Z R，ZHAO J，et al.Professor CHEN Qihua summarized the experience of diagnosis and treatment of breast cancer from "positive deficiency toxin knot"［J］.J Med Inf，2021，34（5）：164-165.
20. 20.
    SI W T，LI Y L，HOU A H.SUN Min's experience in the treatment of breast cancer［J］.J Oncol Chin Med，2022，4（1）：59-63.
21. 21.
    ZHOU Y，ZHENG L X.Analysis of the etiology，pathological transmission and formation of breast cancer［J］.China J Tradit Chin Med Pharm，2020，35（7）：3334-3337.
22. 22.
    ZHU M G.Observation on improvement of adverse reactions after chemotherapy in patients with liver depression and spleen deficiency breast cancer with Chaihu Shugan powder［D］.Nanjing：Nanjing University of Chinese Medicine，2024.
23. 23.
    WAN Y，XIA X，ZHANG M W，et al.Effect of Guipi decoction combined with Sini powder on immune function in breast cancer patients with depression［J］.Liaoning J Tradit Chin Med，2025，doi：.
24. 24.
    LIN H Q，CHEN W J.Advances in TCM research of breast cancer［J］.Tradit Chin Med J，2024，23（1）：67-69.
25. 25.
    CHEN Q J，SITU H L，GUAN R D，et al.A clinical study on cluster analysis of syndrome types in 545 patients with breast cancer in consolidated stage after surgery［J］.Beijing J Tradit Chin Med，2008，27（8）：590-592.
26. 26.
    HU Z H，HUANG H，ZHANG J X，et al.Understanding of the etiology of epidemic pathogenic factors and six climatic exopathogens［J］.Guangming J Chin Med，2024，39（8）：1518-1521.
27. 27.
    ZHANG W J.The literature study on the syndrome treatment regular rule research on Ru-yan［D］.Jinan：Shandong University of Chinese Medicine，2008.
28. 28.
    CHANG L，LU W P.Study on clinical rules of traditional Chinese medicine syndrome differentiation and treatment for breast cancer under the guidance of precision medicine based on data mining［J］.China Med，2022，17（3）：340-344.
29. 29.
    LU W P，WANG X M，MA F.Consensus on diagnosis and treatment of breast cancer with integration of traditional and western medicine［J］.Chin J Front Med Sci：Elec Ed，2021，13（7）：44-64.
30. 30.
    GUAN Y F，CHEN J A，GAO L J，et al.Clinical study on epidemiological characteristics and TCM syndrome distribution of 457 patients with breast cancer［J］.Zhejiang J Integr Tradit Chin West Med，2022，32（9）：864-866.
31. 31.
    ZHANG S J.Study on the characteristics of TCM syndrome elements of breast cancer and its estrogen metabonomics［D］.Fuzhou：Fujian University of Traditional Chinese Medicine，2023.
32. 32.
    CHEN Q J，PEI X H.Consensus on TCM syndrome differentiation and internal therapy for early-stage breast cancer［J］.Mod Chin Clin Med，2020，27（3）：5-8.
33. 33.
    JIANG Y，TAN X，YE S L，et al.WANG Pei's experience in treating breast cancer［J］.China J Tradit Chin Med Pharm，2024，39（3）：1294-1297.
34. 34.
    ZHAO Y.Xihuang pill combined with platinum containing regimen in the treatment of breast cancer of liver stagnation and Qi stagnation type［J］.Guangming J Chin Med，2024，39（6）：1067-1070.
35. 35.
    WANG C，TANG J Y，YAO C，et al.Clinical observation of Sanhuang decoction in treating Qi deficiency and blood stasis syndrome of triple negative breast cancer［J］.China J Tradit Chin Med Pharm，2023，38（11）：5579-5584.
36. 36.
    DI NARDO P，LISANTI C，GARUTTI M，et al.Chemotherapy in patients with early breast cancer：Clinical overview and management of long-term side effects［J］.Expert Opin Drug Saf，2022，21（11）：1341-1355.
37. 37.
    YANG J，GAO W C，HUANG J C.Analysis of syndrome differentiation and treatment experience on breast cancer［J］.China J Tradit Chin Med Pharm，2024，39（6）：2945-2948.
38. 38.
    SUN X G，FENG S H，GUAN X J，et al.Clinical study on gargle with modified Gancao Xiexin decoction for chemotherapy-related oral mucositis［J］.New J Tradit Chin Med，2024，56（3）：1-6.
39. 39.
    LU L T，LU Y X，NI H S.Observation on the curative effect of Huangqi Guizhi Wuwu decoction combined with Buyang Huanwu decoction in the treatment of bone and joint symptoms caused by letrozole［J］.J Pract Tradi Chin Med，2024，40（6）：1073-1075.
40. 40.
    WANG L，CUI X X，WEI H T，et al.Application and research progress of compound Kushen injection combined with western medicine in the treatment of breast cancer［J］.Chin J Ethnomed Ethnopharm，2024，33（13）：54-59.
41. 41.
    ZHANG W X.Analysis of drug use rules in TCM treatment of breast cancer based on TCM inheritance assistance platform［J］.Mod Tradit Chin Med Mater Med-World Sci Technol，2016，18（12）：2143-2147.
42. 42.
    GUI Y，DAI Y F，WANG Y M，et al.Taohong Siwu decoction exerts anticancer effects on breast cancer via regulating MYC，BIRC5，EGF and PIK3R1 revealed by HTS2 technology［J］.Comput Struct Biotechnol J，2022，20：3461-3472.
43. 43.
    CHENG L Y，YAN X L，XING C Y，et al.Effect of Taohong Siwu decoction on protein expression of Bcl-2，Bax，and Ki-67 in invasive breast cancer of Qi stagnation and blood stasis pattern［J］.Basic Tradit Chin Med，2023，2（4）：34-37.
44. 44.
    WENG J Q，LU W P，CUI S S，et al.Effect of Xihuang pill on the proliferation and dry spheroidization ability of 4T1 cells through Wnt /β-catenin pathway［J］.Beijing J Tradit Chin Med，2021，40（9）：968-972.
45. 45.
    XU S，LI R，LIU L P.Danzhi Xiaoyao powder-containing serum reverses energy metabolic reprogramming of MDA-MB-231 breast cancer cells［J］.Chin J Exp Tradit Med Form，2022，28（3）：8-14.
46. 46.
    ZHENG L X，LIU T T，HUANG P，et al.Inhibitory effect of Liuwei Dihuang pill on triple-negative breast cancer through MAPKKK1 and KLF4［J］.Chin J Exp Tradit Med Form，2022，28（11）：16-25.
47. 47.
    ZENG M F，ZHOU Y，WANG X M，et al.Effects and molecular mechanism of Xiaoyao powder combined with Bazhen decoction on tumor growth in spontaneous breast cancer mice［J］.China J Tradit Chin Med Pharm，2021，36（7）：3812-3815.
48. 48.
    ZHANG H Y，SHI Y，ZHOU L N.Effect of Jiandu Zengxiao decoction in the prevention and treatment of abnormal glucose metabolism after the molecular targeted treatment of HER-2 positive breast cancer［J］.Jilin J Chin Med，2022，42（12）：1426-1429.
49. 49.
    FANG Y X，WANG S M，YANG Q，et al.Chaihu Guizhi decoction plus or minus formula combined with capecitabine inhibits IL-6/STAT3 signaling to suppress triple-negative breast cancer xenografts in nude mice［J］.J South Med Univ，2022，42（6）：905-912.
50. 50.
    GAO J L，ZHAO N，ZHANG H，et al.Clinical efficacy of radiotherapy combined with compound Kushen injection in the treatment of breast cancer［J］.Chin J Ration Drug Use，2019，16（2）：27-30.
51. 51.
    YANG W B，YIN X M，YANG H J，et al.Effect of Qingreshengji ointment on acute radiation dermatitis after modified radical surgery for breast cancer［J］.Guangming J Chin Med，2024，39（5）：853-856.
52. 52.
    MAO D，LI L，FENG L.The efficacy study of yanghe decoction combined with gt regimen chemotherapy on stage Ⅳ triple negative breast cancer and its effect on Th17/Treg cell level［J］.Jiangxi J Tradit Chin Med，2023，54（5）：41-43.
53. 53.
    WU C X.Xiaochaihu decoction combined with chemotherapy in the treatment of relapsed and metastatic advanced breast cancer［J］.Chin Med Mod Distance Edu China，2023，21（17）：145-147.
54. 54.
    ZHANG Y，LIU X F，ZHU Q，et al.Study on the prevention and treatment effect of Jiawei Shengmaiyin on the cardiotoxicity caused by Herceptin in HER-2 positive breast cancer［J］.Mod J Integr Tradit Chin West Med，2020，29（24）：2640-2643.
55. 55.
    WANG X X，HOU H，LI Z.Effect of modified Sijunzi decoction on gut microbiota and cellular immune function in patients with breast cancer undergoing postoperative chemotherapy［J］.Chin J Microecol，2023，35（12）：1424-1428.
56. 56.
    XING X R，YIN D F，HU T D.Clinical observation of Bupleurum，Fossil Fragments and Concha Ostreae decoction combined with Retinervus Luffae Fructus and Fructus Liquidambaris in the treatment of upper limb lymphedema after breast cancer operation［J］.J Basic Chin Med.，2018，24（11）：1577-1579.
57. 57.
    QIANG R.Effect of added Banxia Xiexin decoction on menopausal syndrome after endocrine therapy of postmenopausal breast cancer［D］.Beijing：Beijing University of Chinese Medicine，2020.
58. 58.
    CHANG Y，HAN J J，CUI S L，et al.Effect of Yinchenhao decoction on ALT，AST and TBIL in patients with liver injury caused by chemotherapy after breast cancer surgery［J］.Tianjin Pharm，2019，31（5）：64-65.
59. 59.
    YAN Y T，CAO J X.Effective analysis of Xiaozhong Lishui Waifu powder in treating refractory seroma after modified radical mastectomy for breast cancer［J］.Inner Mongolia J Tradit Chin Med，2021，40（3）：106-109.
60. 60.
    WANG J F，SONG W G，LIU W.Effects of Jianpi Fuzheng Runzao decoction on survival and toxic side effects of chemotherapy patients with advanced breast cancer［J］.Chin Arch Tradit Chin Med，2025，.
61. 61.
    TIAN M Z.Clinical observation on treatment with Qingshi Huayu prescription of promoting wound healing of after breast cancer surgery［D］.Jinan：Shandong University of Traditional Chinese Medicine，2020.
62. 62.
    SONG Y H，BAO H Y，WANG J Q，et al.To explore the intervention effect of Shancigu extract on breast cancer rats based on JNK1/AP-1 signaling pathway［J］.Chin J Gerontol，2024，44（14）：3536-3540.
63. 63.
    QIN N，HUANG H P，SHEN X H，et al.Anti-tumor and immunomodulatory effects of Hedyotis diffusa Willd.water extract on human breast cancer MDA-MB-231 transplanted tumor in nude mice［J］.Mod J Integr Tradit Chin West Med，2024，33（8）：1029-1037.
64. 64.
    HABIBI R M，MOHAMMADI R A，DELAZAR A，et al.Effects of Polygonum aviculare herbal extract on proliferation and apoptotic gene expression of MCF-7［J］.Daru，2011，19（5）：326-331.
65. 65.
    XU G G，ZHAO H P，XU J D，et al.Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling［J］.J Ethnopharmacol，2021，269：113705.
66. 66.
    CHANG X，LU T，HUANG J C.Research on the mechanism of Danzhixiaoyao powder treating breast cancer［J］.Chongqing Med J，2023，52（20）：3142-3147.
67. 67.
    ADILIJIANG S， AIMATI M，ZHOU W T，et al.Mechanism of kaempferol-induced apoptosis of adriamycin MCF-7/adriamycin resistant cells［J］.Chin J Clin Pharmacol，2021，37（11）：1380-1384.
68. 68.
    SAFI A，HEIDARIAN E，AHMADI R.Quercetin synergistically enhances the anticancer efficacy of docetaxel through induction of apoptosis and modulation of PI3K/Akt，MAPK/ERK，and JAK/STAT3 signaling pathways in MDA-MB-231 breast cancer cell line［J］.Int J Mol Cell Med，2021，10（1）：11-22.
69. 69.
    CHEN W J，TSAI J H，HSU L S，et al.Quercetin blocks the aggressive phenotype of triple-negative breast cancer by inhibiting IGF1/IGF1R-mediated EMT program［J］.J Food Drug Anal，2021，29（1）：98-112.
70. 70.
    KIM S H，CHOO G S，YOO E S，et al.Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis［J］.Oncol Lett，2021，21（6）：492.
71. 71.
    IQBAL M A，CHATTOPADHYAY S，AHMAD S F，et al.Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis：Potential therapeutic implications［J］.FEBS J，2021，288（2）：471-485.
72. 72.
    CHEN Y，ZHANG J Y，ZHANG M Q，et al.Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α［J］.Clin Transl Med，2021，11（11）：e577.
73. 73.
    SUSMITHA G D，MIYAZATO K，OGURA K，et al.Anti-metastatic effects of baicalein by targeting STAT3 activity in breast cancer cells［J］.Biol Pharm Bull，2020，43（12）：1899-1905.
74. 74.
    SCHERBAKOV A M，ANDREEVA O E.Apigenin inhibits growth of breast cancer cells：The role of ERα and HER2/neu［J］.Acta Naturae，2015，7（3）：133-139.
75. 75.
    LIN C H，CHANG C Y，LEE K R，et al.Flavones inhibit breast cancer proliferation through the Akt/FoxO3a signaling pathway［J］.BMC Cancer，2015，15（1）：958.
76. 76.
    ZHAO M，XU P L，SHI W J，et al.Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer［J］.Cancer Cell Int，2024，24（1）：74.
77. 77.
    SONG L J，CHEN X，MI L，et al.Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer［J］.Cancer Sci，2020，111（11）：4242-4256.
78. 78.
    ZHANG J H，LIU W J，LUO H M.Advances in activities of terpenoids in medicinal plants［J］.Mod Tradit Chin Med Mater Med-World Sci Technol，2018，20（3）：419-430.
79. 79.
    GUAN X，GUAN Y.Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G₂/M cell cycle arrest［J］.J Buon，2020，25（3）：1330-1336.
80. 80.
    CAO Y，FENG Y H，GAO L W，et al.Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo［J］.Int Immunopharmacol，2019，70：110-116.
81. 81.
    ZHAO X，LIU J Y，GE S S，et al.Saikosaponin a inhibits breast cancer by regulating Th1/Th2 balance［J］.Front Pharmacol，2019，10：624.
82. 82.
    WANG J X，QI H，ZHANG X L，et al.Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling［J］.Biomed Pharmacother，2018，108：724-733.
83. 83.
    YE S Y，HU X Y，SUN S W，et al.Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK/Nrf2/HO-1［J］.Eur J Pharmacol，2024，974：176620.
84. 84.
    ZHANG W J，SHI L，ZHOU W，et al.Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K/Akt/mTOR signaling pathway［J］.Heliyon，2023，9（7）：e18046.
85. 85.
    JIANG W，CHEN M J，XIAO C C，et al.Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo［J］.Biol Pharm Bull，2019，42（6）：892-899.
86. 86.
    ZHANG Z W，SUN C F，ZHANG L，et al.Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin［J］.Biomed Pharmacother，2019，109：1541-1546.
87. 87.
    YIN L，FAN Z P，LIU P，et al.Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis［J］.Toxicol Appl Pharmacol，2021，432：115755.
88. 88.
    LIU Y H.Anemoside A₃ inhibits macrophage M2-like polarization to against triple-negative braest cancer metastasis［D］.Nanchang：Jiangxi University of Chinese Medicine，2021.
89. 89.
    FU W，LIU L X，TONG S J.Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA［J］.Thorac Cancer，2024，15（17）：1357-1368.
90. 90.
    HAN B，WANG K，TU Y B，et al.Low-dose berberine attenuates the anti-breast cancer activity of chemotherapeutic agents via induction of autophagy and antioxidation［J］.Dose Response，2020，18（4）：1559325820939751.
91. 91.
    LIU Y L，YAN Z X，XIA Y，et al.Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain （FGG） expression［J］.Am J Cancer Res，2020，10（3）：939-952.
92. 92.
    SHEN J L，ZENG L W，PAN L M，et al.Tetramethylpyrazine regulates breast cancer cell viability，migration，invasion and apoptosis by affecting the activity of Akt and caspase-3［J］.Oncol Lett，2018，15（4）：4557-4563.
93. 93.
    DU J K，LI J W，SONG D B，et al.Matrine exerts anti-breast cancer activity by mediating apoptosis and protective autophagy via the Akt/mTOR pathway in MCF-7 cells［J］.Mol Med Rep，2020，22（5）：3659-3666.
94. 94.
    XIAO X，AO M，XU F，et al.Effect of matrine against breast cancer by downregulating the vascular endothelial growth factor via the Wnt/β-catenin pathway［J］.Oncol Lett，2018，15（2）：1691-1697.
95. 95.
    YE B，WEI J，XIONG Z N，et al.Action mechanism of solanine on improving the sensitivity of human breast cancer MCF-7 cells to cisplatin［J］.J Sichuan Tradit Chin Med，2021，39（10）：44-49.
96. 96.
    LIU H M，LIU Z G，WANG Z P.Solanine increases the sensitivity of doxorubicin-resistant breast cancer cells to doxorubicin by inhibiting the expression of Med19［J］.Chin J Histochem Cytochem，2023，32（1）：41-47.
97. 97.
    XU M R.Effect and its related mechanism of brucine on vasculogenic mimicry in human triple-negative breast cancer cell line MDA-MB-231［D］.Hefei：Anhui Medical University，2019.
98. 98.
    WU J J.Brucine suppresses fatty acid oxidation in triple-negative breast cancer via the PGC-1α/PPARα /CPT1A［D］.Hefei：Anhui Medical University，2022.
99. 99.
    ZHANG M Y，LEI B X，XIE W，et al.Research progress on mechanism of anti-breast cancer action of Chinese herbal monomers［J］.Shanghai J Tradit Chin Med，2023，57（6）：26-40.
100. 100.
     LI W F，HU X Y，LI Y J，et al.Cytotoxicity and growth-inhibiting activity of Astragalus polysaccharides against breast cancer via the regulation of EGFR and ANXA1［J］.J Nat Med，2021，75（4）：854-870.
101. 101.
     YANG S，SUN S Q，XU W Q，et al.Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway［J］.Mol Med Rep，2020，21（4）：1819-1832.
102. 102.
     DU X，ZHANG J J，LIU L，et al.A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells［J］.J Zhejiang Univ Sci B，2022，23（4）：286-299.
103. 103.
     SUN L N，ZUO C L，LIU X X，et al.Combined photothermal therapy and Lycium barbarum polysaccharide for topical administration to improve the efficacy of doxorubicin in the treatment of breast cancer［J］.Pharmaceutics，2022，14（12）：2677.
104. 104.
     ZHOU H L，YAN Y X，ZHANG X B，et al.Ginseng polysaccharide inhibits MDA-MB-231 cell proliferation by activating the inflammatory response［J］.Exp Ther Med，2020，20（6）：229.
105. 105.
     WU W B，ZHU W.Clinical study on Ginseng polysaccharide injection combined with epirubicin in treatment of breast cancer［J］.Drugs Clin，2018，33（8）：2036-2039.
106. 106.
     LIU X Y，LONG F，HUANG Y，et al.Dandelion polysaccharide inhibits proliferation，migration and invasion of MDA-MB-231 cells by down-regulation of LncRNA CCAT1 expression［J］.Chin Tradit Herb Drug，2024，55（4）：1145-1157.
107. 107.
     LIU X Y，LONG F，ZHAO Y，et al.Effect of dandelion polysaccharide on migration and invasion of triple-negative breast cancer cells based on PI3K/Akt/GSK-3β pathway［J］.Nat Prod Res Dev，2023，35（7）：1135-1143.
108. 108.
     LUO Z B，ZENG H X，YE Y Q，et al.Safflower polysaccharide inhibits the proliferation and metastasis of MCF-7 breast cancer cells［J］.Mol Med Rep，2015，11（6）：4611-4616.
109. 109.
     LIU N，ZHU L，LI N，et al.Mechanism research of safflower polysaccharide inducing apoptosis of human breast cancer MDA-MB-435 cells by interrupting PI3K/Akt/mTOR Pathway［J］.Chin Tradit Herb Drug，2018，49（18）：4374-4379.
110. 110.
     AL-SHARIF I，REMMAL A，ABOUSSEKHRA A.Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation［J］.BMC Cancer，2013，13（24）：600.
111. 111.
     ABDULLAH M L，AL-SHABANAH O，HASSAN Z K，et al.Eugenol-induced autophagy and apoptosis in breast cancer cells via PI3K/Akt/FOXO3a pathway inhibition［J］.Int J Mol Sci，2021，22（17）：9243.
112. 112.
     EL-FAR A H，SADDIQ A A，MOHAMED S A，et al.Curcumin and thymoquinone combination attenuates breast cancer cell lines' progression［J］.Integr Cancer Ther，2022，21：1-14.
113. 113.
     ZHU J，LI Q，WU Z P，et al.Curcumin for treating breast cancer：A review of molecular mechanisms，combinations with anticancer drugs，and nanosystems［J］.Pharmaceutics，2024，16（1）：79.
114. 114.
     KOMOROWSKA D，GAJEWSKA A，HIKISZ P，et al.Comparison of the effects of resveratrol and its derivatives on the radiation response of MCF-7 breast cancer cells［J］.Int J Mol Sci，2021，22（17）：9511.
115. 115.
     GAO Y，TOLLEFSBOL T O.Combinational proanthocyanidins and resveratrol synergistically inhibit human breast cancer cells and impact epigenetic（-） mediating machinery［J］.Int J Mol Sci，2018，19（8）：1-18.
116. 116.
     ZHOU J，SU C M，CHEN H A，et al.Cryptotanshinone Inhibits the glycolysis and inhibits cell migration through PKM2/beta-catenin axis in breast cancer［J］.Onco Targets Ther，2020，13：8629-8639.
117. 117.
     LI H Y，GAO C D，LIANG Q，et al.Cryptotanshinone is a intervention for ER-positive breast cancer：An integrated approach to the study of natural product intervention mechanisms［J］.Front Pharmacol，2020，11：592109.
118. 118.
     KHAN M A，ZHENG M L，FU J W，et al.Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro［J］.BMC Cancer，2022，22（1）：707.
119. 119.
     SUN Z X，LI Y Q，ZHANG F C，et al.Origin of the external therapy of traditional Chinese medicine［J］.China J Tradit Chin Med Pharm，2016，31（11）：4416-4419.
120. 120.
     YANG Q L，QUAN J F.Review of treatment of malignant tumors and related diseases with external therapies in Chinese medicine［J］.Jiangsu J Tradit Chin Med，2022，54（2）：77-81.
121. 121.
     ZHANG F C，GAO T Y，ZHANG C X，et al.Effect of moxibustion combined with chemotherapy on tumor immune checkpoints in tumor tissue of breast cancer-bearing mice［J］.Acupunct Res，2025，50（3）：319-326.
122. 122.
     LIU Y X，JIANG Y L，LI J，et al.Effect of pestle needle therapy on lymphedema patients after breast cancer surgery［J］.Chin Evid Based Nurs，2024，10（14）：2578-2582.
123. 123.
     LYU Z，LIU R D，SU K Q，et al.Regulatory effects of acupuncture on gut microbiota in mice with breast cancer related fatigue［J］.Mod Tradit Chin Med Mater Med-World Sci Technol，2023，25（7）：2402-2411.
124. 124.
     FENG X M，SU H Z，GAO F Q，et al.Observation of curative effect of the treatment of lymphedema of upper limb after breast cancer operation with fumigation and washing of traditional Chinese medicine combined with acupoint application of Jiawei Jinhuang ointment［J］.J Mod Oncol，2023，31（7）：1252-1256.
125. 125.
     ZOU N Q.The study of Clinical observation of Tuhuanglian external lotion in preventing acute radiation dermatitis after breast cancer surgery［D］.Guangzhou：Guangzhou University of Chinese Medicine，2022.